Table 3 Cost of drug estimates
| Â | Manufacture | Unit cost (US$) | Recommended dosage/frequency | Cost per cycle (21Â days) (US$) | Cost per month (30Â days) (US$) |
|---|---|---|---|---|---|
Drug therapy costs | |||||
 Sorafenib | Bayer | 857.14 (60*200 mg) | 400 mg twice per day | 1200.00 | 1714.29 |
 Lenvatinib | Eisai | 982.56 (30*4 mg) | 12 mg per day | 2063.37 | 2947.67 |
Atezolizumab-Bevacizumab | |||||
 Atezolizumab | Roche | 4,932.33 (20 ml:1.2 g) | 1200 mg per cycle | 4932.33 | 7053.23 |
 Bevacizumab | Roche | 225.56 (4 ml:100 mg) | 1044 mg per cycle | 2481.20 | 3548.12 |
Sintilimab-Bevacizumab | |||||
 Sintilimab | Xin da | 427.52 (10 ml:100 mg) | 200 mg per cycle | 855.04 | 1222.70 |
 Bevacizumab | Roche | 225.56 (4 ml:100 mg) | 1044 mg per cycle | 2481.20 | 3548.12 |